Skip Navigation

European Heart Journal 1999 20(19):1407-1414; doi:10.1053/euhj.1999.1578
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jørgensen, B
Right arrow Articles by Thaulow, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jørgensen, B
Right arrow Articles by Thaulow, E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids

B Jørgensena,f1, S Simonsena, K Endresena, K Forfanga, T Egelandb, A.T Høstmarkc and E Thaulowa

a Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway
b Epidemiological Center, Rikshospitalet, University of Oslo, Oslo, Norway
c Department of Preventive Medicine, University of Oslo, Oslo, Norway

revised February 24, 1999; accepted March 3, 1999 1999

Abstract

Aims Lipoproteins and lipids, especially lipoprotein(a), have been studied as risk factors for restenosis after coronary angioplasty with conflicting results. We investigated the association between serum levels of lipoprotein(a) apolipoprotein A-1, apolipoprotein B-100, total-cholesterol, high density lipoprotein-cholesterol, triglycerides, and coronary luminal loss and restenosis after angioplasty.

Methods The lipoproteins and lipids were measured in 305 consecutive patients who underwent successful angioplasty and reangiography 20±3 weeks after angioplasty. Single-vessel dilatation was performed in 251 patients. Luminal loss was defined as minimal luminal diameter post-angioplasty minus minimal luminal diameter at follow-up, divided by the interpolated reference diameter of the vessel. Restenosis was defined according to three dichotomous categorical criteria: (1) >50% diameter stenosis at follow-up (2) loss of >50% of the gain achieved by angioplasty, (3) the need for target vessel revascularization.

Results There was no significant association between the serum levels of lipoproteins and lipids and luminal loss. Univariate analysis did not show any significant difference in the serum levels of any of the lipoproteins and lipids between the restenosis and no-restenosis groups. Multivariate analysis revealed that only the angiographic variables (luminal gain and post-angioplasty minimal luminal diameter) were associated with luminal loss and restenosis after angioplasty.

Conclusion Lipoproteins and lipids were neither associated with luminal loss nor independent risk factors for restenosis after angioplasty.

Key Words: Angioplasty, lipoproteins, lipids, restenosis

f1 Correspondence: Bjørn Jørgensen, MD, Hjertemedisinsk avdeling, Rikshospitalet, N-0027 Oslo, Norway.

References

  1. Genest JJ, McNamara JR, Ordovas JM. Lipoprotein cholesterol, apolipoprotein A-1 and B are lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol. 1992;19:792–802[Abstract]
  2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986;2:933–936[CrossRef][Web of Science][Medline]
  3. Rose G, Shipley M. Plasma cholesterol concentrations and deaths from coronary heart disease. Br Med J. 1986;293:306–307[Abstract/Free Full Text]
  4. Schwartzman RA, Cox ID, Poloniecki J, Crook R, Seymour CA, Kaski JC. Elevated plasma lipoprotein (a) is associated with coronary disease in patients with chronic stable angina pectoris. J Am Coll Cardiol. 1998;31:1260–1266[Abstract/Free Full Text]
  5. Cooke T, Sheahan R, Foley D. Lipoprotein (a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 1994;89:1593–1598[Abstract/Free Full Text]
  6. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758–765[Abstract/Free Full Text]
  7. Miyata M, Biro S, Arima S, Hamasaki S, Kaieda H, Nakao S, Kawataki M, Nomoto S, Tanaka H. High serum concentration of serum lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal angioplasty in Japanese with single-vessel disease. Am Heart J. 1996;132:269–273[CrossRef][Web of Science][Medline]
  8. Yamamoto H, Imazu M, Yamabe T, Ueda H, Hattori Y, Yamakido M. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: Role of lipoprotein (a). Am Heart J. 1995;130:1168–1173[CrossRef][Web of Science][Medline]
  9. Hearn JA, Donohue BC, Ba'albaki H. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1992;69:736–739[CrossRef][Web of Science][Medline]
  10. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein (a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995;91:1403–1409[Abstract/Free Full Text]
  11. Shah P, Amin J. Low high density lipoprotein is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992;85:1279–1285[Abstract/Free Full Text]
  12. Dzavik V, Teo KK, Yokoyama S. Effect of serum lipid concentration on restenosis after successful angioplasty in patients with total cholesterol 160 to 240mg/dl and triglycerides <350mg/dl. Am J Cardiol. 1995;75:936–937[CrossRef][Web of Science][Medline]
  13. Poonam A, Hoffman CJ, Korlipara G, Neuroth A, Dervan JP, Lawson WE, Hultin MB. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty. Arterioscler Thromb Vasc Biol. 1998;18:1281–1286[Abstract/Free Full Text]
  14. Labeur C, De Backuer G, Vincke J. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem. 1992;38:2261–2266[Abstract/Free Full Text]
  15. Jenner JL, Ordovas JM, Lamon-Favo S. Effects of age, sex, and menopausal status on plasma lipoprotein(a) plasma lipoprotein (a) levels. The Framingham offspring study. Circulation. 1993;87:1135–1141[Abstract/Free Full Text]
  16. Braeckman L, De Bacquer D, Rosseneu M, De Backer G. Determinants of lipoprotein (a) in a middle-aged working population. Eur Heart J. 1996;17:1808–1813[Abstract/Free Full Text]
  17. Rensing BJ, Hermans WRM, Deckers JW, de Feyter PJ, Tijssen JGP, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1445 successfully dilated lesions. J Am Coll Cardiol. 1992;19:939–945[Abstract]
  18. Violaris AG, Melkert R, Serruys PW. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions. Circulation. 1994;90:2267–2279[Abstract/Free Full Text]
  19. Serruys PW, Foley DP, Kirkeeide RL, King SB. Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J. 1993;126:1243–1267[CrossRef][Web of Science][Medline]
  20. Thaulow E, Jørgensen B. Clinical promise of calcium antagonists in the angioplasty patient. Eur Heart J. 1997;18:B21–B26
  21. Jørgensen B, Simonsen S, Forfang K, Endresen K, Vatne K, Erikssen J, Thaulow E. Coronary angioplasty amlodipine restenosis study. Results from CAPARES (Abstr). J Am Coll Cardiol. 1998;31:2989
  22. Haase J, Mario CD, Slager CJ. In-vivo validation of on-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries. Cathet Cardiovasc Diagn. 1992;27:16–27[Web of Science][Medline]
  23. Serruys PW, Foley DP, de Feyter PJ. Quantitative Coronary Angiography in Clinical Practice. Dordrecht, Boston, London: Kluwer Academic Publishers; 1994.
  24. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 1994;90:1239–1251[Abstract/Free Full Text]
  25. Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation. 1993;88:1310–1323[Free Full Text]
  26. Faxon DP. Identifying the predictors of restenosis. Do we need new glasses. Circulation. 1997;95:2244–2246[Free Full Text]
  27. Bourassa MG, Lespérance J, Eastwood C. Clinical, physiologic, anatomic, and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Cardiol. 1991;18:368–376
  28. Foley DP, Melkert R, Umans VA, de Jaegere PP, Strikwerda S, de Feyter PJ, Serruys PW. Differences in restenosis propensity of devices for transluminal coronary intervention. Eur Heart J. 1995;16:1331–1346[Abstract/Free Full Text]
  29. MBewu AD, Durrington PN. Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis. 1990;85:1–14[CrossRef][Web of Science][Medline]
  30. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science. 1993;260:1655–1658[Abstract/Free Full Text]
  31. Horie H, Takahashi M, Izumi M. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Circulation. 1997;96:166–173
  32. Umans VA, Robert A, Foley D. Clinical, histologic and quantitative angiographic predictors of restenosis after directional coronary atherectomy: a multivariate analysis of the renarrowing process and late outcome. J Am Coll Cardiol. 1994;23:49–58[Abstract]
  33. Cigolini M, Seidell JC, Zenti MG. Serum Lp(a) levels in randomized healthy men from different european countries. Eur J Epidemiol. 1993;9:497–503[Web of Science][Medline]
  34. Altman DG. Why transform data. Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991. p. 143–146
  35. Foley JB, Yonger K, Foley DP. Lipids and fatty acids and their relationship to restenosis. Cathet Cardiovasc Diagn. 1992;25:25–30[Web of Science][Medline]
  36. Rensing BJ, Hermans WRM, Vos J. Angiographic risk factors of luminal narrowing after balloon measurements to reflect stretch and elastic recoil at the dilatation site. Am J Cardiol. 1992;69:584–591[CrossRef][Web of Science][Medline]
  37. Nobuyoshi M, Kimura T, Hideyuki N. Restenosis after successful precutaneous coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12:616–623[Abstract]
  38. Serruys PW, Luijten HE, Beatt KJ. Incidence of restenosis after successful angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, og 4 month. Circulation. 1988;77:361–371[Abstract/Free Full Text]
  39. Bertrand ME, McFadden EP, Fruchart J-C. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. J Am Coll Cardiol. 1997;30:863–869[Abstract]
  40. Weintraub WS, Boccuzzi SJ, Klein L. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med. 1994;331:1331–1337[Abstract/Free Full Text]
  41. Kostner GM, Gavish B, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989;80:1313–1319[Abstract/Free Full Text]
  42. Serruys PW, Foley DP. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty. Eur Heart J. 1999;20:58–69[Abstract/Free Full Text]
  43. Currier JW, Faxon DP. Restenosis after transluminal coronary angioplasty: Have we been aiming at the wrong target. J Am Coll Cardiol. 1995;25:516–520[Abstract]
  44. Baptista J, di Mario C, Escaned J. Intracoronary two-dimensional ultrasound imaging in the assessment of plaque morphologic features and the planning of coronary interventions. Am Heart J. 1995;129:177–187[CrossRef][Web of Science][Medline]
  45. Andersen HR, Mæng M, Thorwest M, Falk E. Remodelling rather than neointimal formation explains luminal narrowing after deep vessel wall injury, insights from a porcine coronary (re)stenosis model. Circulation. 1996;93:1716–1724[Abstract/Free Full Text]
  46. Potkin BN, Keren G, Mintz GS. Arterial responses to arterial coronary angioplasty: an intravascular ultrasound study. J Am Coll Cardiol. 1992;20:942–951[Abstract]
  47. Mintz GS, Pichard AD, Kent KM, Slater LF, Popma JJ, Leon MB. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol. 1994;74:1278–1280[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
P.J. de Feyter
Editorials: Lipids and coronary restenosis: an elusive link
Eur. Heart J., October 1, 1999; 20(19): 1371 - 1374.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jørgensen, B
Right arrow Articles by Thaulow, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jørgensen, B
Right arrow Articles by Thaulow, E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?